These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7532294)

  • 1. Antibody-dependent neutrophil-mediated parasite killing in non-lethal rodent malaria.
    Waki S
    Parasite Immunol; 1994 Nov; 16(11):587-91. PubMed ID: 7532294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of recombinant human colony-stimulating factor on the course of parasitaemia in non-lethal rodent malaria.
    Waki S; Kurihara R; Nemoto H; Suzuki M
    Parasitol Res; 1993; 79(8):703-5. PubMed ID: 7507593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to an attenuated variant of Plasmodium berghei: role of some non-specific factors.
    Waki S; Nakazawa S; Taverne J; Targett GA; Playfair JH
    Parasitology; 1985 Oct; 91 ( Pt 2)():263-72. PubMed ID: 3906521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage Plasmodium berghei XAT infection.
    Yoneto T; Waki S; Takai T; Tagawa Yi ; Iwakura Y; Mizuguchi J; Nariuchi H; Yoshimoto T
    J Immunol; 2001 May; 166(10):6236-41. PubMed ID: 11342646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infections of mice.
    Waki S; Uehara S; Kanbe K; Nariuch H; Suzuki M
    Parasite Immunol; 1995 Oct; 17(10):503-8. PubMed ID: 8587787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium berghei XAT: contribution of gammadelta T cells to host defense against infection with blood-stage nonlethal malaria parasite.
    Kobayashi F; Niikura M; Waki S; Matsui T; Fujino T; Tsuruhara T; Kamiya S
    Exp Parasitol; 2007 Dec; 117(4):368-75. PubMed ID: 17601562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
    Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In-vivo enhancement of neutrophil function by administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in cyclophosphamide (CPA) treated mice].
    Yoshida M
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):518-27. PubMed ID: 1375670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
    Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5866-73. PubMed ID: 14676108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic/pharmacodynamic analysis of neutrophil proliferation induced by recombinant granulocyte colony-stimulating factor (rhG-CSF): comparison between intravenous and subcutaneous administration.
    Sugiura M; Yamamoto K; Sawada Y; Iga T
    Biol Pharm Bull; 1997 Jun; 20(6):684-9. PubMed ID: 9212991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice.
    Hebert JC; O'Reilly M; Gamelli RL
    Arch Surg; 1990 Aug; 125(8):1075-8. PubMed ID: 1696096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J; Zhao XY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
    Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
    Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model.
    Hernandez-Ilizaliturri FJ; Jupudy V; Reising S; Repasky EA; Czuczman MS
    Leuk Lymphoma; 2005 Dec; 46(12):1775-84. PubMed ID: 16263581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomics and proteomic analyses between lethal and nonlethal strains of Plasmodium berghei.
    Niikura M; Inoue SI; Fukutomi T; Yamagishi J; Asahi H; Kobayashi F
    Exp Parasitol; 2018 Feb; 185():1-9. PubMed ID: 29307564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inductive potential of recombinant human granulocyte colony-stimulating factor to mature neutrophils from x-irradiated human peripheral blood hematopoietic progenitor cells.
    Katsumori T; Yoshino H; Hayashi M; Takahashi K; Kashiwakura I
    Biol Pharm Bull; 2009 Nov; 32(11):1849-53. PubMed ID: 19881296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
    Teshima H; Ishikawa J; Kitayama H; Yamagami T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
    Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice.
    Misaki M; Ueyama Y; Tsukamoto G; Matsumura T
    Br J Cancer; 1998 Mar; 77(6):884-9. PubMed ID: 9528829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice.
    Matsuzaki G; Li XY; Ohyama Y; Nomoto K
    Int J Immunopharmacol; 1996; 18(6-7):363-9. PubMed ID: 9024937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different membrane expression of CD11b and CD14 on blood neutrophils following in vivo administration of myeloid growth factors.
    Hansen PB; Kjaersgaard E; Johnsen HE; Gram J; Pedersen M; Nikolajsen K; Hansen NE
    Br J Haematol; 1993 Sep; 85(1):50-6. PubMed ID: 7504510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.